Cargando…
Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
Repositioning or repurposing drugs account for a substantial part of entering approval pipeline drugs, which indicates that drug repositioning has huge market potential and value. Computational technologies such as machine learning methods have accelerated the process of drug repositioning in the la...
Autores principales: | Zhu, Sha, Bai, Qifeng, Li, Lanqing, Xu, Tingyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189996/ https://www.ncbi.nlm.nih.gov/pubmed/35765655 http://dx.doi.org/10.1016/j.csbj.2022.05.057 |
Ejemplares similares
-
Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020) -
Development of Pigmentation-Regulating Agents by Drug Repositioning
por: Jeong, Seo-Mi-Gon, et al.
Publicado: (2021) -
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014) -
DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020) -
Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning
por: Zhang, Cheng, et al.
Publicado: (2022)